Annual FCF
-$211.39 M
-$24.63 M-13.19%
31 December 2023
Summary:
Rocket Pharmaceuticals annual free cash flow is currently -$211.39 million, with the most recent change of -$24.63 million (-13.19%) on 31 December 2023. During the last 3 years, it has fallen by -$82.51 million (-64.02%). RCKT annual FCF is now -3174.79% below its all-time high of -$6.46 million, reached on 31 December 2013.RCKT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$53.69 M
+$2.06 M+3.70%
30 September 2024
Summary:
Rocket Pharmaceuticals quarterly free cash flow is currently -$53.69 million, with the most recent change of +$2.06 million (+3.70%) on 30 September 2024. Over the past year, it has dropped by -$19.70 million (-57.98%). RCKT quarterly FCF is now -2794.39% below its all-time high of -$1.85 million, reached on 31 March 2014.RCKT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$202.32 M
+$8.11 M+3.85%
30 September 2024
Summary:
Rocket Pharmaceuticals TTM free cash flow is currently -$202.32 million, with the most recent change of +$8.11 million (+3.85%) on 30 September 2024. Over the past year, it has increased by +$9.07 million (+4.29%). RCKT TTM FCF is now -10806.79% below its all-time high of -$1.85 million, reached on 31 March 2014.RCKT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCKT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -58.0% | +4.3% |
| 3 y3 years | -64.0% | -62.8% | -57.0% |
| 5 y5 years | -140.4% | -85.2% | -130.1% |
RCKT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.0% | at low | -62.8% | +13.1% | -57.0% | +14.5% |
| 5 y | 5 years | -140.4% | at low | -153.5% | +13.1% | -130.1% | +14.5% |
| alltime | all time | -3174.8% | at low | -2794.4% | +13.1% | <-9999.0% | +14.5% |
Rocket Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$53.69 M(-3.7%) | -$202.32 M(-3.9%) |
| June 2024 | - | -$55.75 M(-5.3%) | -$210.43 M(+0.4%) |
| Mar 2024 | - | -$58.89 M(+73.3%) | -$209.70 M(-0.8%) |
| Dec 2023 | -$211.39 M(+13.2%) | -$33.99 M(-45.0%) | -$211.39 M(-10.7%) |
| Sept 2023 | - | -$61.80 M(+12.3%) | -$236.69 M(+8.0%) |
| June 2023 | - | -$55.02 M(-9.2%) | -$219.25 M(+6.3%) |
| Mar 2023 | - | -$60.58 M(+2.2%) | -$206.16 M(+10.4%) |
| Dec 2022 | -$186.76 M(+44.9%) | -$59.28 M(+33.6%) | -$186.76 M(+16.4%) |
| Sept 2022 | - | -$44.36 M(+5.8%) | -$160.46 M(+8.9%) |
| June 2022 | - | -$41.94 M(+1.8%) | -$147.35 M(+1.3%) |
| Mar 2022 | - | -$41.18 M(+24.8%) | -$145.44 M(+12.9%) |
| Dec 2021 | -$128.88 M(+24.3%) | -$32.98 M(+5.5%) | -$128.88 M(+4.0%) |
| Sept 2021 | - | -$31.25 M(-21.9%) | -$123.92 M(+8.8%) |
| June 2021 | - | -$40.03 M(+62.7%) | -$113.85 M(+13.6%) |
| Mar 2021 | - | -$24.61 M(-12.2%) | -$100.24 M(-3.3%) |
| Dec 2020 | -$103.70 M(+17.9%) | -$28.03 M(+32.3%) | -$103.70 M(-0.9%) |
| Sept 2020 | - | -$21.18 M(-19.8%) | -$104.66 M(+3.6%) |
| June 2020 | - | -$26.42 M(-5.9%) | -$101.04 M(+1.8%) |
| Mar 2020 | - | -$28.07 M(-3.2%) | -$99.27 M(+12.9%) |
| Dec 2019 | -$87.93 M | -$28.99 M(+65.1%) | -$87.93 M(+9.0%) |
| Sept 2019 | - | -$17.56 M(-28.8%) | -$80.64 M(+7.3%) |
| June 2019 | - | -$24.65 M(+47.3%) | -$75.17 M(+24.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$16.74 M(-22.9%) | -$60.37 M(+9.3%) |
| Dec 2018 | -$55.24 M(+111.0%) | -$21.70 M(+79.5%) | -$55.24 M(+12.7%) |
| Sept 2018 | - | -$12.09 M(+22.8%) | -$49.02 M(+19.5%) |
| June 2018 | - | -$9.85 M(-15.2%) | -$41.03 M(+20.9%) |
| Mar 2018 | - | -$11.61 M(-25.0%) | -$33.94 M(+29.6%) |
| Dec 2017 | -$26.18 M(-30.6%) | -$15.48 M(+278.0%) | -$26.18 M(+19.1%) |
| Sept 2017 | - | -$4.09 M(+48.7%) | -$21.98 M(-19.0%) |
| June 2017 | - | -$2.75 M(-28.5%) | -$27.13 M(-16.8%) |
| Mar 2017 | - | -$3.85 M(-65.8%) | -$32.60 M(-13.7%) |
| Dec 2016 | -$37.75 M(+111.8%) | -$11.28 M(+22.1%) | -$37.75 M(+12.3%) |
| Sept 2016 | - | -$9.24 M(+12.4%) | -$33.60 M(+16.0%) |
| June 2016 | - | -$8.22 M(-8.7%) | -$28.98 M(+16.7%) |
| Mar 2016 | - | -$9.01 M(+26.3%) | -$24.84 M(+39.3%) |
| Dec 2015 | -$17.83 M(+83.0%) | -$7.13 M(+54.6%) | -$17.83 M(+30.2%) |
| Sept 2015 | - | -$4.62 M(+12.9%) | -$13.69 M(+14.9%) |
| June 2015 | - | -$4.09 M(+105.1%) | -$11.91 M(+20.5%) |
| Mar 2015 | - | -$1.99 M(-33.4%) | -$9.88 M(+1.4%) |
| Dec 2014 | -$9.74 M(+50.9%) | -$2.99 M(+5.5%) | -$9.74 M(+44.4%) |
| Sept 2014 | - | -$2.84 M(+37.9%) | -$6.75 M(+72.5%) |
| June 2014 | - | -$2.06 M(+10.9%) | -$3.91 M(+110.9%) |
| Mar 2014 | - | -$1.85 M | -$1.85 M |
| Dec 2013 | -$6.46 M(-6.9%) | - | - |
| Dec 2012 | -$6.94 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly FCF year-on-year change?
- What is Rocket Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM FCF year-on-year change?
What is Rocket Pharmaceuticals annual free cash flow?
The current annual FCF of RCKT is -$211.39 M
What is the all time high annual FCF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual free cash flow is -$6.46 M
What is Rocket Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RCKT is -$53.69 M
What is the all time high quarterly FCF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly free cash flow is -$1.85 M
What is Rocket Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RCKT quarterly free cash flow has changed by -$19.70 M (-57.98%)
What is Rocket Pharmaceuticals TTM free cash flow?
The current TTM FCF of RCKT is -$202.32 M
What is the all time high TTM FCF for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM free cash flow is -$1.85 M
What is Rocket Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RCKT TTM free cash flow has changed by +$9.07 M (+4.29%)